|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current assets | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Investments held in trust | |||||
| Total current assets | |||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||
| Current liabilities | |||||
| Accounts payable to related party | |||||
| Accrued expenses | |||||
| Deferred underwriting compensation | |||||
| Total current liabilities | |||||
| Deferred underwriting compensation | |||||
| Total liabilities | |||||
| Class A common stock subject to possible redemption, 23,002,500 at March 31, 2023 and December 31, 2022, respectively, at redemption value of $10.30 per share | |||||
| Stockholders' deficit | |||||
| Class B common stock; $0.0001 par value, 25,000,000 shares authorized, 5,750,100 shares issued and outstanding | |||||
| Class B Common Stock | |||||
| Total class B common stock; $0.0001 par value, 25,000,000 shares authorized, 5,750,100 shares issued and outstanding | |||||
| Accumulated deficit | |||||
| Total Kimbell Tiger Acquisition Corporation equity | |||||
| Non-controlling interest in subsidiary | |||||
| Total stockholders' deficit | |||||
| Total liabilities and stockholders' deficit |
Loading...
